Researchers have identified a protein that could slow the spread of lung cancer and lead to the development of new cancer drugs.
Research shows that a protein called RBM10 can slow the growth of lung cancer. It does this by inhibiting another protein called c-Myc, which normally causes cancer cells to multiply.
The findings were published in the journal Proceedings of the National Academy of Sciences.
Lung cancer is the second most frequently diagnosed form of cancer in men in Europe. Around 320,000 people in EU countries were expected to be newly diagnosed with it in 2020.
Current treatments include surgery, chemotherapy, radiotherapy and immunotherapy.
